Greg Wells

University of Sheffield — United Kingdom

Medicine · Health Sciences

6h-index123citations22works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(6), 3D Printing in Biomedical Research(4), Cancer Genomics and Diagnostics(4), Glioma Diagnosis and Treatment(3), Ionosphere and magnetosphere dynamics(3)

Publications22 total

Ex Vivo Drug Screening: An Emerging Paradigm in the Treatment of Childhood Cancer
Journal of Pediatric Hematology/Oncology·2025
Ex-vivo drug efficacy assessment using 2D and 3D culture assays for personalised cancer therapy
2025Open Access
Turning the tide: harnessing vaccines and viruses to fight cancer
Immunotherapy Advances·2024Open Access
SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia
Cell Death and Disease·2024· 10 citedOpen Access
408 (PB396): Building insights on the latest novel cancer drugs using pan-cancer ex vivo trials
European Journal of Cancer·2024
1781P Multi-omics of soft tissue sarcomas with complex karyotypes: Investigating genomic and transcriptomic differences between cell lines of the same subtype
Annals of Oncology·2024Open Access
In-vitro assays for immuno-oncology drug efficacy assessment and screening for personalized cancer therapy: scopes and challenges
Expert Review of Clinical Immunology·2024· 5 citedOpen Access
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients
F1000Research·2024· 1 citedOpen Access
2302P Efficacy assessment of targeted and immunotherapies for personalised treatment of melanoma using 2D and 3D ex-vivo assays
Annals of Oncology·2023· 1 citedOpen Access
DEVELOPMENT OF GLIEXP; A HIGH-THROUGHPUT EX VIVO DRUG SCREENING PLATFORM FOR GLIOBLASTOMA
Neuro-Oncology·2023Open Access
Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients
F1000Research·2023· 11 citedOpen Access
Precision oncology using ex vivo technology: a step towards individualised cancer care?
Expert Reviews in Molecular Medicine·2022· 25 citedOpen Access
<i>Ex vivo</i> analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma
Oncotarget·2021· 6 citedOpen Access
The Psychosocial Benefits of Recreational Oncology Camp for Childhood Cancer Patients and Survivors: Study Protocol (Preprint)
2020Open Access
7 Assessing melanoma BRAF status through ddPCR of cfDNA
Postgraduate Medical Journal·2019
Assessing melanoma BRAF status through ddPCR of cfDNA
Annals of Oncology·2019· 1 citedOpen Access
Genome-Wide Analysis of Circulating Cell-Free DNA Copy Number Detects Active Melanoma and Predicts Survival
Clinical Chemistry·2018· 10 citedOpen Access
Identifying functionally important aberrations of Neurofibromin-1 (NF1) in non-small cell lung cancer (NSCLC)
European Journal of Surgical Oncology·2018· 1 cited
Identifying functionally important aberrations of Neurofibromin-1 (NF1) in non-small cell lung cancer (NSCLC)
European Journal of Surgical Oncology·2017
The variability of Joule heating, and its effects on the ionosphere and thermosphere
Annales Geophysicae·2001· 45 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Sarah Danson(15), Juha Rantala(8), Ola Rominiyi(6), Hannah Gagg(5), Thomas Helleday(5), Spencer J. Collis(5), Munitta Muthana(4), A. S. Rodger(3), R. J. Moffett(3), G. J. Bailey(3), Sophie Williams(3), Samantha Conroy(3), Katie Myers(3), Connor McGarrity-Cottrell(3), Callum Jones(3), Ian W. Brock(3), Angela Cox(3), M M Rahman(3), Shobha Silva(2), T. J. Fuller‐Rowell(2)